On May, 9 Syneos Health, Inc. (SYNH) Analysts See $0.44 EPS

April 17, 2018 - By Mark Mitchell

Syneos Health, Inc. (NASDAQ:SYNH)’s quarterly earnings will be revealed On May, 9., Zacks reports. Analysts forecast $0.44 EPS, which is $0.09 down or 16.98 % from 2017’s $0.53 EPS. SYNH’s profit could be $45.67 million with 21.42 P/E in case $0.44 EPS is revealed. -34.33 % negative EPS growth is what Wall Street’s forecasts after $0.67 reported EPS last quarter. SYNH reached $37.7 on during the last trading session after $0.05 change.Syneos Health, Inc. has volume of 517,087 shares. Since April 17, 2017 SYNH has 0.00% and is . The stock underperformed the S&P500 by 11.55%.

Syneos Health, Inc., a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries in North America, Europe, the Middle East and Africa, the Asia-Pacific, and Latin America.The firm is worth $3.91 billion. The firm offers a range of services focusing on Phase I to Phase IV clinical trials in central nervous system, oncology, and other complex therapeutic areas.Currently it has negative earnings. The Company’s services include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, and regulatory and medical writing; and data services consisting of clinical data management, electronic data capture, and biostatistics.

Syneos Health, Inc. (NASDAQ:SYNH) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.